EVELUT(R): dyspnoea and symptom burden in COPD patients switching from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS

Conclusion: As per GOLD recommendations, dyspnoeic patients on LABA/ICS without an indication to continue ICS can be switched to T/O LAMA/LABA, with TT showing no benefit versus T/O with regards to symptoms and health status.

Source: European Respiratory Journal - December 1, 2022 Category: Respiratory Medicine Authors: Buhl, R., Dreher, M., Mattiucci-Guehlke, M., Eckhardt, S., Taube, C., Vogelmeier, C., Buhl, R. Tags: 05.01 - Airway pharmacology and treatment Source Type: research